NEW YORK, September 9, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding Costco Wholesale Corporation (NASDAQ: COST), CVS Caremark Corp (NYSE: CVS), Target Corp. (NYSE: TGT), Lumber Liquidators Holdings, Inc. (NYSE: LL) and Pandora Media, Inc. (NYSE: P). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6315-100free.
--
Costco Wholesale Corporation Research Reports
On September 4, 2014, Costco Wholesale Corporation (Costco) announced net sales for month of August 2014 at $8.8 billion, an increase of 10.0% YoY. Costco's comparable sales during the month rose 7%, beating the average forecast of 4.8% in a Reuters' poll of analysts. For Q4 FY 2014 (period ended August 31, 2014), Costco's net sales increased 9.4% YoY to $34.8 billion, and comparable sales climbed 6%. For FY 2014, the Company reported net sales of $110.2 billion, an increase of 7.1% YoY, while comparable sales increased 4% during this period. Shares of the Company jumped 3.13% to end the session at $125.15 following the announcement. The full research reports on Costco are available to download free of charge at:
http://www.analystsreview.com/Sep-09-2014/COST/report.pdf
--
CVS Caremark Corp Research Reports
On September 3, 2014, CVS Caremark Corp (CVS) announced that it is changing its corporate name to CVS Health to reflect the Company's broader health care commitment, in-line with which it is also discontinuing the sale of tobacco products at its pharmacies. CVS Health comprises of the Company's retail business (CVS/pharmacy), pharmacy benefit management business (CVS/caremark), walk-in medical clinics (CVS/minuteclinic), and specialty pharmacy services (CVS/specialty). The Company added that effective from the date of announcement, CVS/Pharmacy stores will not sell tobacco products. CVS stated that the decision to eliminate cigarettes and tobacco products from sale in CVS/Pharmacy stores comes a month sooner than planned. The Company also kicked off a smoking cessation campaign to help millions of Americans to quit smoking. The full research reports on CVS are available to download free of charge at:
http://www.analystsreview.com/Sep-09-2014/CVS/report.pdf
--
Target Corp. Research Reports
On September 4, 2014, Target Corp. (Target) announced the availability of flu vaccines at all of its Target Pharmacy and Target Clinic locations nationwide, as the cold and flu season kicks in. The Company will offer guests Quadrivalent, Trivalent and High Dose, while FluMist will be available later this month. According to the Company, the Centers for Disease Control and Prevention (CDC) has recommended that anyone older than 6 months of age be vaccinated against the flu. "At Target, we know that prevention is key when it comes to keeping families healthy during the cold and flu season," said Kevin Ronneberg, MD, Medical Director, Target. The full research reports on Target are available to download free of charge at:
http://www.analystsreview.com/Sep-09-2014/TGT/report.pdf
--
Lumber Liquidators Holdings, Inc. Research Reports
On September 4, 2014, the stock of Lumber Liquidator Holdings, Inc. (Lumber Liquidator) shed some gains following the previous session's sharp rally. Shares in Lumber Liquidator fluctuated between $55.82 and $59.09 before finally settling with a decline of 2.02% at $58.08. The stock had gained 7.14% in the previous trading session. Over the last one month, the Company's stock has increased by 3.86%, in line with the Dow Jones Industrial Average which increased 3.90% during that period. Lumber Liquidator's stock is currently trading below its 50-day and 200-day moving averages of $59.77 and $85.20, respectively. The full research reports on Lumber Liquidators are available to download free of charge at:
http://www.analystsreview.com/Sep-09-2014/LL/report.pdf
--
Pandora Media, Inc. Research Reports
On September 4, 2014, Pandora Media, Inc. (Pandora) announced that its CFO Mike Herring will present at the Goldman Sachs 23rd Annual Communacopia Conference in New York. Pandora informed that Herring will participate in a fireside chat on September 11, 2014 at 8:20 a.m. PT / 11:20 a.m. ET. A live audio webcast of the presentation can be accessed on Pandora's Investor Relations website. The full research reports on Pandora are available to download free of charge at:
http://www.analystsreview.com/Sep-09-2014/P/report.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
